Medical Mycology Case Reports (Dec 2020)

Renal transplant patient survives a donor-derived abdominal invasive mucormycosis (Lichtheimia ramosa)

  • E.M. Spithoven,
  • A.H.W. Bruns,
  • B.J. Petri,
  • P.J. Haas,
  • T.Q. Nguyen,
  • F. Hagen,
  • A.D. van Zuilen

Journal volume & issue
Vol. 30
pp. 39 – 42

Abstract

Read online

Mucormycosis is a life-threatening invasive fungal infection, most commonly described in severely immunocompromised patients. It is characterized by rapid invasive growth of the fungus and often with fatal outcome. We report a case of a renal transplant recipient diagnosed with a donor-derived invasive mucormycosis. In this patient, we used a step-wise approach of withdrawal of immunosuppressants, antifungal induction therapy, extensive surgical debridement of all (potentially) infected tissue, abdominal irrigation of liposomal amphotericin B and interferon gamma. Due to rapid diagnosis and intensive therapy the patient survived.

Keywords